n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Aura in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hill, TC; Holman, BL; Lee, RG; O'Leary, DH; Polak, JF; Royal, HD | 1 |
Hill, TC; Holman, BL; Royal, HD | 1 |
1 review(s) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Aura
Article | Year |
---|---|
Clinical brain imaging with isopropyl-iodoamphetamine and SPECT.
Topics: Amphetamines; Animals; Brain; Cerebrovascular Disorders; Dementia; Epilepsy; Humans; Iodine Radioisotopes; Iodobenzenes; Iofetamine; Radiation Dosage; Tissue Distribution; Tomography, Emission-Computed | 1985 |
1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Aura
Article | Year |
---|---|
Cerebral perfusion imaging with iodine 123-labeled amines.
Topics: Amines; Amphetamines; Cerebrovascular Disorders; Electroencephalography; Epilepsy; Humans; Iodine Radioisotopes; Iodobenzenes; Iofetamine; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1984 |